TMO
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc historical holders
total: 22
TCI Fund Management Thermo Fisher Scientific Inc transactions over time
- Total transactions:
- 7
- New positions:
- 1
- Sold out:
- 1
- Added:
- 3
- Reduced:
- 2
- Held since:
- 2022 Q4
- Held for:
- 6 quarters
- Latest activity:
- 2024 Q2
Chris Hohn has been an institutional investor in Thermo Fisher Scientific Inc (TMO) since 2022 Q4. According to 2026 Q1 report, Chris Hohn doesn't hold any shares. The fund/company first acquired TMO in 2022 Q4, initially purchasing 63,770 shares. Since the initial investment, TCI Fund Management has made 6 more transactions in this position.
When did Chris Hohn exit their TMO position?
Chris Hohn no longer holds Thermo Fisher Scientific Inc (TMO). They sold off their entire position in 2024 Q2, closing out an investment that began in 2022 Q4.
When did Chris Hohn first invest in TMO?
Chris Hohn first invested in Thermo Fisher Scientific Inc (TMO) in 2022 Q4 at the reported quarter-end price of $550.69 per share, acquiring 63,770 shares in their initial purchase.
What is Chris Hohn's average cost basis for TMO?
Based on historical transaction data, Chris Hohn's estimated cost basis for Thermo Fisher Scientific Inc (TMO) is approximately $535.41 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $535.41
- Weighted AVG sell price:
- $580.47
TMO transactions history by TCI Fund Management
7 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2024 Q2
|
0.00%
|
0
|
$581.21
|
|
-100% (-1,517,639)
|
-2.22%
|
|
2024 Q1
|
2.22%
|
1,517,639
|
$581.21
|
$882,066,963
|
-51.77% (-1,628,743)
|
-2.63%
|
|
2023 Q4
|
4.64%
|
3,146,382
|
$530.79
|
$1,670,068,102
|
-1.47% (-46,800)
|
-0.09%
|
|
2023 Q3
|
5.86%
|
3,193,182
|
$506.17
|
$1,616,292,933
|
+0.63% (+20,000)
|
+0.04%
|
|
2023 Q2
|
4.92%
|
3,173,182
|
$521.75
|
$1,655,607,709
|
+280.41% (+2,339,032)
|
+3.62%
|
|
2023 Q1
|
1.65%
|
834,150
|
$576.37
|
$480,779,036
|
+1,208.06% (+770,380)
|
+1.52%
|
|
2022 Q4
|
0.12%
|
63,770
|
$550.69
|
$35,117,501
|
new
|
+0.12%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.